[Temporary Announcement] Ipnocon: Announcement of being adjusted to the basic level
Announcement number: 2026-025
Securities code: 835852 Securities abbreviation: Ipnocon Sponsored securities firm: Guoyuan Securities
Anhui Yipu Nokang Biotechnology Co., Ltd.
Announcement of being adjusted to the base layer
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.
1. Downgrade adjustment
Level before adjustment: Innovation level
Level after adjustment: Basic layer
Effective date of downgrading adjustment: June 16, 2026
On June 8, 2026, the National Equities Exchange and Quotations Co., Ltd. (hereinafter referred to as the National Equities Exchange and Quotations) announced "About the Release of Beijing Jiuzhou Dadi Biotechnology Group Co., Ltd. and other 90 "Announcement on the Decision of an Innovative Level Company to Downgrade" (Stock Transfer Announcement [2026] No. 200), made a decision to downgrade Anhui Ipnocon Biotechnology Co., Ltd. (hereinafter referred to as the "Company"). The main contents are as follows: The company's net profits have been negative in the past three years, and its operating income has continued to decline in the past two years, triggering the downgrade situation stipulated in Article 14 (1) of the "National Small and Medium-sized Enterprises Share Transfer System Stratified Management Measures" and being transferred to the basic level.
According to the relevant provisions of the "Review Implementation Rules of the National Equities Exchange and Quotations for Small and Medium-sized Enterprises", if a listed company has objections to the downgrade decision, it shall submit a review application to the National Equities Exchange and Quotations within 5 trading days from the date of the announcement of the share transfer. If the review application is not submitted within the prescribed time limit or the review application is not accepted, the National Equities Exchange and Quotations will transfer them to the basic tier starting from June 16, 2026.
The company has no objection to the downgrade decision made by the National Equities Exchange and Quotations and has not submitted a review application. The company will be transferred from the innovation level to the basic level on June 16, 2026, and will not be allowed to enter the innovation level again within 12 months from the date of adjustment to the basic level. The company will continue to perform relevant information disclosure work in strict accordance with the relevant requirements of the National Equities Exchange and Quotations. Investors are kindly requested to pay attention to investment risks and make prudent decisions.
Announcement number: 2026-025
2. Documents for reference
"Announcement on the Release of the Decision to Downgrade 90 Innovation Level Companies including Beijing Jiuzhou Dadi Biotechnology Group Co., Ltd." (Share Transfer Announcement [2026] No. 200)
Board of Directors of Anhui Yipu Nokang Biotechnology Co., Ltd.
June 15, 2026